The Quantitative Biosciences Institute (QBI) was established in 2016 as an organized research unit (ORU) within the School of Pharmacy at the University of California-San Francisco.[1][2][3][4] The current director of QBI is Nevan Krogan.[5][1]
History
In 1993, Irwin Kuntz, created an ORU within the School of Pharmacy, called the Molecular Design Institute (MDI). The Dean of the School of Pharmacy, B. Joseph Guglielmo with the support of the UCSF campus and the UC Office of the President transformed MDI into QBI.[5]
Previously, QBI was a part of QB3, also known as QB3-UCSF.[4] In March 2016, UCSF established QBI as a Organized Research Unit (ORU) within the School of Pharmacy.[5]
QBI Coronavirus Research Group
The institute formed the QBI Coronavirus Research Group (QCRG), a collaborative group of labs, aimed at finding solutions for COVID-19.[1][2][6][7][8]
References
- 1 2 3 Fagone, Jason (2020-04-30). "UCSF team has discovered drugs that block coronavirus, paving way for 'a better drug sooner'". San Francisco Chronicle. Retrieved 2022-02-01.
- 1 2 "Cracking the coronavirus: How UCSF scientists raced to decode the deadly disease". San Francisco Chronicle. 2020-05-01. Retrieved 2022-02-01.
- ↑ "Serendipitous Discovery Leads to a New Understanding of How Cells Multitask". Lab Manager. Retrieved 2022-02-01.
- 1 2 "QBI". QB3. Retrieved 2022-02-01.
- 1 2 3 "UCSF Establishes Quantitative Biosciences Institute | UC San Francisco". www.ucsf.edu. 16 March 2016. Retrieved 2022-02-01.
- ↑ "eFFECTOR and QBI to study anti-viral agent for Covid-19 treatment". Pharmaceutical Technology. 2021-05-05. Retrieved 2022-02-01.
- ↑ "Alpha Coronavirus Variant Evolved to Evade Immune System | UC San Francisco". www.ucsf.edu. 28 December 2021. Retrieved 2022-02-01.
- ↑ "How UC fought COVID-19 in 2020". University of California. 2021-01-13. Retrieved 2022-02-01.